Fidelity Investments Portfolio holdings
Fidelity Investments, founded in 1946 by Edward C. Johnson II and headquartered in Boston, Massachusetts, is one of the largest privately-held financial services firms in the world, managing hundreds of billions in assets. Known for its wide array of investment products, including mutual funds, retirement accounts, brokerage services, and wealth management, Fidelity caters to both individual investors and institutions with a reputation for strong customer service and innovative tools like its active trader platforms. The company pioneered direct-to-investor mutual fund sales, bypassing traditional brokers, and has since expanded into areas like cryptocurrency trading and commission-free stock trades. Still family-controlled by the Johnson family, Fidelity blends a legacy of traditional investing with a forward-looking approach to technology and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$4.92B |
| 2 |
Becton Dickinson
BDX
|
+$4.13B |
| 3 |
Wells Fargo
WFC
|
+$3.81B |
| 4 |
Tesla
TSLA
|
+$2.09B |
| 5 |
GE Aerospace
GE
|
+$1.76B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Toronto Dominion Bank
TD
|
+$2.28B |
| 2 |
Royal Bank of Canada
RY
|
+$1.77B |
| 3 |
Rogers Communications
RCI
|
+$1.25B |
| 4 |
Suncor Energy
SU
|
+$1.23B |
| 5 |
TWX
Time Warner Inc
TWX
|
+$1.14B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.34% |
| 2 | Financials | 16.14% |
| 3 | Healthcare | 14.65% |
| 4 | Consumer Discretionary | 11.8% |
| 5 | Communication Services | 10.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Neurocrine Biosciences
NBIX
$16.8B
| $1.32B | 0.15% |
13,451,201
+60,325
| +0.5% | +$5.4M |
|
127
Constellation Brands
STZ
$22.2B
| $1.31B | 0.15% |
5,969,243
+337,338
| +6% | +$76.2M |
|
128
Sherwin-Williams
SHW
$82.7B
| $1.3B | 0.15% |
9,540,015
-1,454,277
| -13% | -$188M |
|
129
Ryanair
RYAAY
$30.4B
| $1.29B | 0.15% |
28,243,923
-2,918,200
| -9% | -$136M |
|
130
Sarepta Therapeutics
SRPT
$1.57B
| $1.29B | 0.15% |
9,749,879
+82,453
| +0.9% | +$7.78M |
|
131
Cigna
CI
$73.8B
| $1.29B | 0.15% |
7,561,105
+734,965
| +11% | +$127M |
|
132
Huntington Bancshares
HBAN
$34.4B
| $1.28B | 0.15% |
86,970,523
-9,390,329
| -10% | -$141M |
|
133
Micron Technology
MU
$930B
| $1.27B | 0.15% |
24,302,624
-2,622,350
| -10% | -$142M |
|
134
JD.com
JD
$44.6B
| $1.27B | 0.15% |
32,682,794
-10,536,917
| -24% | -$406M |
|
135
Goldman Sachs
GS
$300B
| $1.27B | 0.15% |
5,765,111
-3,212,266
| -36% | -$766M |
|
136
Nektar Therapeutics
NKTR
$2.39B
| $1.26B | 0.14% |
1,713,727
+107,256
| +7% | +$124M |
|
137
Nike
NKE
$61.9B
| $1.25B | 0.14% |
15,661,001
+219,743
| +1% | +$15.5M |
|
138
State Street
STT
$50.6B
| $1.22B | 0.14% |
13,153,308
-1,298,267
| -9% | -$129M |
|
|
PXD
139
DELISTED
Pioneer Natural Resource Co.
PXD
| $1.22B | 0.14% |
6,431,051
+1,401,626
| +28% | +$268M |
|
140
PTC
PTC
$15.8B
| $1.22B | 0.14% |
12,971,985
-803,788
| -6% | -$69.5M |
|
141
American International
AIG
$41.7B
| $1.2B | 0.14% |
22,621,535
+8,149,702
| +56% | +$441M |
|
142
Marvell Technology
MRVL
$168B
| $1.2B | 0.14% |
55,789,566
+2,685,377
| +5% | +$57.3M |
|
143
Equinix
EQIX
$101B
| $1.18B | 0.14% |
2,745,542
-656,563
| -19% | -$265M |
|
|
BLUE
144
DELISTED
bluebird bio
BLUE
| $1.18B | 0.14% |
580,381
+1,572
| +0.3% | +$3.58M |
|
145
iShares MSCI Japan ETF
EWJ
$21.9B
| $1.17B | 0.13% |
20,229,158
-975,747
| -5% | -$58.8M |
|
146
Hilton Worldwide
HLT
$72.1B
| $1.16B | 0.13% |
14,625,187
+6,763,660
| +86% | +$550M |
|
147
Baker Hughes
BKR
$60B
| $1.15B | 0.13% |
34,773,486
-2,757,415
| -7% | -$93.6M |
|
148
Cognizant
CTSH
$24.9B
| $1.15B | 0.13% |
14,527,271
-8,688,446
| -37% | -$683M |
|
149
T-Mobile US
TMUS
$185B
| $1.15B | 0.13% |
19,182,040
-2,412,524
| -11% | -$143M |
|
150
Jazz Pharmaceuticals
JAZZ
$15.9B
| $1.14B | 0.13% |
6,634,958
+715,595
| +12% | +$117M |
|
Similar funds
Fidelity Investments's Q2 2018 Portfolio in Review
As of Q2 2018, Fidelity Investments held 2,816 positions worth $869B, up 3.1% from $842B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Fidelity Investments's Q2 2018 filing shows 156 new, 1,047 increased, 1,190 reduced and 191 closed positions. Its largest new stake was Wyndham Hotels & Resorts: 7,888,883 shares worth $464M. The largest sale was Toronto Dominion Bank, an estimated $2.28B.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.
- Fidelity Investments's largest Q2 2018 buy was Wyndham Hotels & Resorts: 7,888,883 shares worth $464M.
- Fidelity Investments added most to Amgen in Q2 2018, an estimated $4.92B increase.
- Fidelity Investments's biggest Q2 2018 reduction was Toronto Dominion Bank, cutting an estimated $2.28B.
- Fidelity Investments fully exited Time Warner Inc in Q2 2018, selling an estimated $1.14B.
- Fidelity Investments's ten largest holdings make up 20% of its $869B portfolio in Q2 2018.
- Fidelity Investments opened 156 new positions and closed 191 in Q2 2018.
- Fidelity Investments's portfolio value rose 3.1% quarter-over-quarter to $869B.
Based on Fidelity Investments's 13F filing for Q2 2018, filed 10 Aug 2018.